314 related articles for article (PubMed ID: 37402856)
61. Roles of the gut microbiota in severe SARS-CoV-2 infection.
Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
[TBL] [Abstract][Full Text] [Related]
62. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
Cyprian F; Sohail MU; Abdelhafez I; Salman S; Attique Z; Kamareddine L; Al-Asmakh M
Int J Infect Dis; 2021 Apr; 105():540-550. PubMed ID: 33610778
[TBL] [Abstract][Full Text] [Related]
63. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID.
Stefano GB
Med Sci Monit; 2021 Feb; 27():e931447. PubMed ID: 33633106
[TBL] [Abstract][Full Text] [Related]
64. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens.
Singh V; Upadhyay P; Reddy J; Granger J
Int J Infect Dis; 2021 Apr; 105():617-620. PubMed ID: 33640570
[TBL] [Abstract][Full Text] [Related]
65. Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolites.
Zhang D; Weng S; Xia C; Ren Y; Liu Z; Xu Y; Yang X; Wu R; Peng L; Sun L; Zhu J; Liang X; Jia Y; Wang H; Chen Q; Liu D; Chen Y; Guo H; Han X; Jin Z; Chen C; Yang X; Li Z; Huang H
BMC Med; 2023 Jul; 21(1):264. PubMed ID: 37468867
[TBL] [Abstract][Full Text] [Related]
66. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.
Zuo T; Liu Q; Zhang F; Yeoh YK; Wan Y; Zhan H; Lui GCY; Chen Z; Li AYL; Cheung CP; Chen N; Lv W; Ng RWY; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Microbiome; 2021 Apr; 9(1):91. PubMed ID: 33853691
[TBL] [Abstract][Full Text] [Related]
67. Targeting the gut-lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection.
Conte L; Toraldo DM
Ther Adv Respir Dis; 2020; 14():1753466620937170. PubMed ID: 32600125
[TBL] [Abstract][Full Text] [Related]
68. Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms.
Mendes de Almeida V; Engel DF; Ricci MF; Cruz CS; Lopes ÍS; Alves DA; d' Auriol M; Magalhães J; Machado EC; Rocha VM; Carvalho TG; Lacerda LSB; Pimenta JC; Aganetti M; Zuccoli GS; Smith BJ; Carregari VC; da Silva Rosa E; Galvão I; Dantas Cassali G; Garcia CC; Teixeira MM; André LC; Ribeiro FM; Martins FS; Saia RS; Costa VV; Martins-de-Souza D; Hansbro PM; Marques JT; Aguiar ERGR; Vieira AT
Gut Microbes; 2023 Dec; 15(2):2249146. PubMed ID: 37668317
[TBL] [Abstract][Full Text] [Related]
69. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
70. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
[TBL] [Abstract][Full Text] [Related]
71. An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota.
Li S; Zhou Y; Yan D; Wan Y
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016396
[TBL] [Abstract][Full Text] [Related]
72. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
73. Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model.
Seibert B; Cáceres CJ; Cardenas-Garcia S; Carnaccini S; Geiger G; Rajao DS; Ottesen E; Perez DR
Microbiol Spectr; 2021 Sep; 9(1):e0053621. PubMed ID: 34378965
[TBL] [Abstract][Full Text] [Related]
74. Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
Galperine T; Choi Y; Pagani JL; Kritikos A; Papadimitriou-Olivgeris M; Méan M; Scherz V; Opota O; Greub G; Guery B; Bertelli C;
BMC Infect Dis; 2023 Aug; 23(1):537. PubMed ID: 37596518
[TBL] [Abstract][Full Text] [Related]
75. Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support.
Giovanetti M; Pannella G; Altomare A; Rocchi G; Guarino M; Ciccozzi M; Riva E; Gherardi G
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543736
[TBL] [Abstract][Full Text] [Related]
76. Intermodulation of gut-lung axis microbiome and the implications of biotics to combat COVID-19.
S A; K G; A AM
J Biomol Struct Dyn; 2022; 40(24):14262-14278. PubMed ID: 34699326
[TBL] [Abstract][Full Text] [Related]
77. Coronavirus disease 2019 and the gut-lung axis.
Zhou D; Wang Q; Liu H
Int J Infect Dis; 2021 Dec; 113():300-307. PubMed ID: 34517046
[TBL] [Abstract][Full Text] [Related]
78. Gastrointestinal microbiota: A predictor of COVID-19 severity?
Neag MA; Vulturar DM; Gherman D; Burlacu CC; Todea DA; Buzoianu AD
World J Gastroenterol; 2022 Dec; 28(45):6328-6344. PubMed ID: 36533107
[TBL] [Abstract][Full Text] [Related]
79. Virus infection induced pulmonary fibrosis.
Huang WJ; Tang XX
J Transl Med; 2021 Dec; 19(1):496. PubMed ID: 34876129
[TBL] [Abstract][Full Text] [Related]
80. SARS-CoV-2-associated Henoch-Schönlein purpura in a 13-year-old girl.
Borocco C; Lafay C; Plantard I; Gottlieb J; Koné-Paut I; Galeotti C
Arch Pediatr; 2021 Oct; 28(7):573-575. PubMed ID: 34393023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
